ClinConnect ClinConnect Logo
Search / Trial NCT06884436

Preoperative Cardiology Consultation and the Incidence of Major Adverse Cardiac Events(MACE)

Launched by CHINESE PLA GENERAL HOSPITAL · Mar 13, 2025

Trial Information

Current as of April 30, 2025

Completed

Keywords

Cardiology Consultation Major Adverse Cardiac Events Preoperative Elderly Electrocardiogram

ClinConnect Summary

Background Preoperative electrocardiogram (ECG) is one of the important methods for perioperative assessment. It can reflect the patient's cardiac condition to a certain extent and indicate the potential risk of major adverse cardiac events (MACE). When a patient has an abnormal preoperative ECG, the standard medical procedure is to consult with a cardiologist to assess cardiac risk and adjust cardiac function, thereby reducing the incidence of adverse cardiac events. However, some studies suggest that cardiology consultation may delay surgery for elderly fracture patients and that consulta...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 65 years;
  • Preoperative ECG results available.
  • Exclusion Criteria:
  • Age \< 65 years;
  • Accepted cardiac or neuro surgery;
  • Second surgery within 30 days post-operation;
  • Patient refused to follow up.

About Chinese Pla General Hospital

The Chinese PLA General Hospital, a prominent military medical institution in Beijing, serves as a leading sponsor for clinical trials, focusing on advancing healthcare through innovative research and development. Renowned for its comprehensive medical services and cutting-edge research capabilities, the hospital is committed to improving patient outcomes through rigorous scientific investigation and collaboration with various stakeholders in the healthcare sector. With a multidisciplinary approach and a strong emphasis on evidence-based practices, the Chinese PLA General Hospital aims to contribute significantly to the global medical community by facilitating the development of safe and effective therapeutic interventions.

Locations

Beijing, , China

Patients applied

0 patients applied

Trial Officials

Jingsheng Lou, PhD & MD

Principal Investigator

The First Medical Center, Chinese PLA General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported